{"url_path":"/fda/drug/recalls/D-0509-2026","section_key":"summary","section_title":"DRUG Recall: Water-Jel Technologies, LLC — Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-07","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0509-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Water-Jel Technologies, LLC"},"word_count":73,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0509-2026\n\n**Recalling firm:** Water-Jel Technologies, LLC\n**Classification:** Class III\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-07\n**Report date:** 2026-05-06\n\n## Product\nLidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950\n\n## Reason\nFailed PH Specifications\n\n## Affected lots\nLots: A5014, A5018, A5019\n\n## Distribution\nNationwide in the USA"}